Breast Cancer in Asia: Incidence, Mortality, Early Detection, Mammography Programs, and Risk-Based Screening Initiatives

Yu Xian Lim; Zi Lin Lim; Peh Joo Ho; Jingmei Li

doi:10.3390/cancers14174218

Breast Cancer in Asia: Incidence, Mortality, Early Detection, Mammography Programs, and Risk-Based Screening Initiatives

Cancers (Basel). 2022 Aug 30;14(17):4218. doi: 10.3390/cancers14174218.

Authors

Yu Xian Lim¹, Zi Lin Lim¹, Peh Joo Ho^{1

2}, Jingmei Li^{1

3}

Affiliations

¹ Genome Institute of Singapore, Laboratory of Women's Health & Genetics, Singapore 138672, Singapore.
² Saw Swee Hock School of Public Health, National University of Singapore, Singapore 117549, Singapore.
³ Department of Surgery, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117597, Singapore.

Abstract

Close to half (45.4%) of the 2.3 million breast cancers (BC) diagnosed in 2020 were from Asia. While the burden of breast cancer has been examined at the level of broad geographic regions, literature on more in-depth coverage of the individual countries and subregions of the Asian continent is lacking. This narrative review examines the breast cancer burden in 47 Asian countries. Breast cancer screening guidelines and risk-based screening initiatives are discussed.

Keywords: Asian breast cancers; mammography screening; risk-based screening.

Publication types

Review

Abstract

Publication types

Grants and funding